Norris M D, Kwan E, Haber M, Marshall G M
Children's Leukaemia and Cancer Research Centre, Prince of Wales Children's Hospital, Sydney, New South Wales, Australia.
Leukemia. 1995 Oct;9(10):1779-82.
The use of the polymerase chain reaction (PCR) to amplify clonal immunoglobulin heavy-chain (IgH) gene rearrangements appears to be a particularly promising technique for detecting minimal residual disease (MRD). However, a major obstacle to successful implementation of this technique involves the problem of clonal evolution, in which instability of the VHDJH region leads to the generation of further rearrangements of the IgH gene over time. Such clonal evolution results in a high likelihood of false negative results when detecting MRD using clone-specific primers based on the rearrangement present at diagnosis. Since in acute lymphoblastic leukemia (ALL), clonal evolution commonly involves alterations of the VHD joining but not the DJH joining, we have devised a novel PCR strategy to circumvent the problem of false negativity in these evolved leukemias. The strategy, which involves construction of overlapping clone-specific DJH primers for use with a consensus VH segment primer, can be used to amplify both evolved and nonevolved ALL populations with high sensitivity and specificity. The method does not require radioactivity and should prove valuable for improving the effectiveness of PCR-based detection of residual leukemia.
利用聚合酶链反应(PCR)扩增克隆性免疫球蛋白重链(IgH)基因重排,似乎是检测微小残留病(MRD)的一项特别有前景的技术。然而,成功应用该技术的一个主要障碍涉及克隆进化问题,即随着时间推移,VHDJH区域的不稳定性会导致IgH基因产生进一步重排。当使用基于诊断时存在的重排的克隆特异性引物检测MRD时,这种克隆进化极有可能导致假阴性结果。由于在急性淋巴细胞白血病(ALL)中,克隆进化通常涉及VHD连接的改变而非DJH连接的改变,我们设计了一种新的PCR策略来规避这些进化型白血病中假阴性的问题。该策略包括构建与共有VH区段引物一起使用的重叠克隆特异性DJH引物,可用于以高灵敏度和特异性扩增进化型和未进化型ALL群体。该方法不需要放射性,对于提高基于PCR的残留白血病检测的有效性应具有重要价值。